A group of clinical experts, scientists and advisors worldwide seeking to optimize care for vulnerable children in limited resource settings
Child Health Task Force panel discussion on CHAIN with representatives from WHO, UNICEF & USAAID.
The CHAIN cohort study found that young children in sub-Saharan Africa and South Asia who become sick or malnourished continue to have a high risk of death in the six months after being hospitalized.
To learn more about findings from the CHAIN cohort study, please visit:
Read Bangladesh news coverage:
The Business Standard
The Financial Express
Bangladesh and Beyond
Read Burkina Faso news coverage (French language):
Université Joseph KI-ZERBO
Watch our CHAIN webinar “Childhood mortality during and after illness”:
On the Front line
We are delighted to share a new video created by our early career researchers and Al Davies called ‘On the Frontline’. It explores the idea of frontline researchers as a critical bridge between communities and research institutions and funders, offering important insights into the ethical dilemmas they face while also challenging simplistic generalisations about ‘vulnerable populations’ in the research context. Hats off to the team for adapting to the limits of lockdown around the world and lending their creativity and voices to this work! Please do share across your networks and feel free to use in teaching/training sessions:
The CHAIN Network is focused on optimizing the management and care of the sick and undernourished child in resource-limited settings to improve survival, growth and development.
The CHAIN Network aims to identify the biological mechanisms and the socio-economic factors that determine a child’s risk of mortality in the six months following presentation to medical care with an acute illness.
CHAIN Burkina Faso site has been focused on the university of Ouagadougou newsletter. Read more…
CHAIN Network Sites Are Across The Globe
The CHAIN Network aims to identify the biological mechanisms and the socio-economic factors that determine a child’s risk of mortality.
The Network will serve as a platform for substantive clinical trials that are led within the group in order to inform policy